WO2010101126A1 - 表面改質基板並びにバイオチップ及びその製造方法 - Google Patents
表面改質基板並びにバイオチップ及びその製造方法 Download PDFInfo
- Publication number
- WO2010101126A1 WO2010101126A1 PCT/JP2010/053278 JP2010053278W WO2010101126A1 WO 2010101126 A1 WO2010101126 A1 WO 2010101126A1 JP 2010053278 W JP2010053278 W JP 2010053278W WO 2010101126 A1 WO2010101126 A1 WO 2010101126A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substrate
- functional group
- biochip
- silanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CN(*)ON(C)OC Chemical compound CN(*)ON(C)OC 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Definitions
- the present invention relates to a surface modified substrate, a biochip, a biochip manufacturing method, a biosensor, and an analysis method.
- polymers having a phosphorylcholine group are known as biocompatible polymers, and biocompatible materials in which various resin materials are coated with such polymers are known.
- Patent Document 1 a monomer having a phosphorylcholine-like group in the side chain, a copolymer of a monomer having a group capable of binding to heparin or a heparin derivative, and heparin or a heparin derivative on the surface of a substrate.
- a medical material in which a coating layer is formed is disclosed.
- Patent Document 2 discloses a ratio between the amount P of phosphorus element derived from phosphorylcholine-like groups and the amount C of carbon elements in a spectrum having phosphorylcholine-like groups at least on the surface and measured by X-ray photoelectron spectroscopy of the surface.
- a separating material having (P / C) of 0.002 to 0.3 is disclosed.
- a material coated with a polymer having a phosphorylcholine group has a problem that a biological substance is easily adsorbed because the phosphorylcholine group cannot be introduced at a high density.
- the present invention provides a surface-modified substrate and a biochip capable of suppressing the adsorption of biological substances, a method for producing the biochip, a biosensor having the biochip, and the biochip
- An object is to provide an analysis method using a sensor.
- the invention according to claim 1 is a surface-modified substrate having a functional group reactive to the reactive functional group and a general formula on the substrate having a reactive functional group on the surface.
- R 1 , R 2 and R 3 are each independently an alkyl group having 1 to 6 carbon atoms, m is an integer of 2 to 6 and n is 1 or 2) is there.) It is manufactured by making the compound which has group represented by react.
- the invention according to claim 2 is the surface modified substrate according to claim 1, wherein the reactive functional group generates an amino group, a hydroxyl group, an aldehyde group, a carboxyl group, or a silanol group by hydrolysis. It is at least one selected from the group consisting of possible functional groups and silanol groups.
- the invention according to claim 3 is manufactured by reacting the surface-modified substrate according to claim 1 with a ligand having a functional group reactive to the reactive functional group in the biochip. It is characterized by being.
- the invention according to claim 4 is a method for producing a biochip, in which a substrate having a reactive functional group on the surface is reacted with a ligand having a functional group reactive to the reactive functional group; A substrate reacted with the ligand, a functional group reactive to the reactive functional group, and a general formula
- R 1 , R 2 and R 3 are each independently an alkyl group having 1 to 6 carbon atoms, m is an integer of 2 to 6 and n is 1 or 2) is there.) It has the process of making the compound which has group represented by these react.
- the invention according to claim 5 is characterized in that the biochip is manufactured by using the biochip manufacturing method according to claim 4.
- the invention according to claim 6 is characterized in that the biosensor has the biochip according to claim 3 or 5.
- the invention according to claim 7 is characterized in that, in the analysis method, the biosensor according to claim 6 is used to analyze a substance that specifically binds to the ligand.
- a surface modified substrate and a biochip capable of suppressing the adsorption of a biological substance, a method for producing the biochip, a biosensor having the biochip, and an analysis method using the biosensor. be able to.
- the surface-modified substrate of the present invention is a substrate having a reactive functional group on the surface, a functional group having a reactivity with the reactive functional group, and a general formula
- R 1 , R 2 and R 3 are each independently an alkyl group having 1 to 6 carbon atoms, m is an integer of 2 to 6 and n is 1 or 2).
- R 1 , R 2 and R 3 are each independently an alkyl group having 1 to 6 carbon atoms, m is an integer of 2 to 6 and n is 1 or 2).
- the reactive functional group on the surface of the substrate is not particularly limited, but an amino group, a hydroxyl group, an aldehyde group, a carboxyl group, a functional group capable of generating a silanol group by hydrolysis, a silanol group Etc., and two or more of them may be used in combination.
- examples of the functional group capable of generating a silanol group by hydrolysis include a hydrosilyl group, an alkoxysilyl group, a halosilyl group, an acyloxysilyl group, and an aminosilyl group. From the viewpoint of stability, reactivity, and the like. An alkoxysilyl group having 1 to 6 carbon atoms or a hydrosilyl group is preferable.
- the material constituting the substrate having such a reactive functional group on the surface may be either an organic material or an inorganic material.
- the organic material is not particularly limited, but styrene, glycidyl methacrylate, (meth) acrylic acid, N-alkylacrylamide, alkyl (meth) acrylate, aminoalkyl (meth) acrylate, hydroxyalkyl (meth) acrylate, etc.
- acrylic acid-N-isopropylacrylamide-methylenebisacrylamide copolymer 2-hydroxyethyl methacrylate-styrene-divinylbenzene copolymer, 2-aminoethyl methacrylate-N-isopropylacrylamide-methylenebisacrylamide copolymer, etc.
- organic materials other than these include agarose and sepharose.
- inorganic materials include, but are not limited to, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, red mica, biotite, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, Barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstic metal salt, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (baked gypsum), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, Metal soap (for example, zinc myristate, calcium palmitate, aluminum stearate), boron nitride, cerium oxide and the like can be mentioned.
- silica, titanium oxide, zinc white, alumina, iron oxide, talc, mica, sericite and the like are preferable.
- substrate may be used.
- Examples of methods for introducing amino groups on the surface of the substrate include plasma treatment, a method of reacting a surface treatment agent, and a silicon gas phase treatment.
- amino groups are introduced into the surface of particles by low-temperature plasma under a nitrogen gas atmosphere (for example, Surface and Coatings Technology 116-119 (1999) 802-807, Colloids and Surfaces A: Physicochem. Eng. Aspects 195 ( 2001) 81-95, Macromol. Chem. Phys. 200.989-996 (1999)).
- the substrate is accommodated in a reaction vessel, the inside of the reaction vessel is evacuated with a vacuum pump, nitrogen gas is introduced, and glow discharge is performed.
- an amino group is introduced onto the surface of a substrate having a silanol group, an alkoxysilyl group or the like using a surface treatment agent such as an alkoxysilane having an amino group, chlorosilane, or silazane.
- a surface treatment agent such as an alkoxysilane having an amino group, chlorosilane, or silazane.
- the substrate is immersed in a water / 2-propanol mixed solution, and 3-aminopropyltrimethoxysilane is added, and then heated to 100 ° C. and reacted for 6 hours. Next, after cooling to room temperature, it is washed with methanol and dried.
- Materials constituting the substrate include organic materials such as 3-trimethoxysilylpropyl methacrylate-methyl methacrylate-divinylbenzene copolymer; silica, glass, alumina, talc, clay, mica, asbestos, titanium oxide, zinc white And inorganic materials such as iron oxide.
- 1,3,5,7-tetramethylcyclotetrasiloxane is used to introduce a hydrosilyl group to the surface of the substrate and then react with a monomer having an amino group to thereby react amino groups on the surface of the substrate.
- a group is introduced (for example, see Japanese Patent Publication No. 1-54379, Japanese Patent Publication No. 1-54380, Japanese Patent Publication No. 1-54381). Specifically, first, the substrate and 1,3,5,7-tetramethylcyclotetrasiloxane are placed in a desiccator and deaerated with an aspirator. Next, after reacting at 80 ° C. for 16 hours, the substrate is taken out and dried at 120 ° C.
- the obtained substrate is immersed in ethanol, allylamine is added, and then an ethanol solution of chloroplatinic acid is added and stirred at 60 ° C. for 2 hours. After the reaction is completed, it is washed with ethanol and dried under reduced pressure.
- Examples of the material constituting the substrate include organic materials such as styrene-divinylbenzene copolymer; inorganic materials such as mica, talc, kaolin, alumina, titanium oxide, zinc oxide, and iron oxide.
- the monomer having an amino group is not limited to allylamine, and may be a vinyl monomer having an amino group, an acrylic monomer, or the like.
- the amino group may be protected with a butoxycarbonyl group, a benzyloxycarbonyl group, or the like.
- a monomer having a functional group capable of introducing an amino group for example, by reaction with a diamine, such as an epoxy group, may be used.
- Examples of a method for introducing an aldehyde group onto the surface of the substrate include a method in which glutaraldehyde is reacted with a substrate having an amino group on the surface.
- Examples of a method for introducing a carboxyl group onto the surface of the substrate include a method in which a surface treatment agent is reacted, a silicone gas phase treatment, and the like.
- a carboxyl group is introduced onto the surface of the substrate having a silanol group, an alkoxysilyl group or the like using a surface treatment agent such as alkoxysilane, chlorosilane, or silazane having a carboxyl group.
- a surface treatment agent such as alkoxysilane, chlorosilane, or silazane having a carboxyl group.
- triethoxysilylpropyl succinic anhydride is dissolved in N, N-dimethylformamide, distilled water and 4-dimethylaminopyridine are added, and the mixture is stirred at room temperature for 16 hours to give a silane having a carboxyxyl group.
- a coupling agent is synthesized.
- the substrate is immersed in a water / 2-propanol mixed solution, and after adding a silane coupling agent having a carboxyl group, the substrate is heated to 100 ° C. and reacted for 6 hours. Further, after cooling to room temperature, it is washed with methanol and dried.
- Materials constituting the substrate include organic materials such as 3-trimethoxysilylpropyl methacrylate-methyl methacrylate-divinylbenzene copolymer; silica, glass, alumina, talc, clay, mica, asbestos, titanium oxide, zinc white And inorganic materials such as iron oxide.
- 1,3,5,7-tetramethylcyclotetrasiloxane is used to introduce a hydrosilyl group to the surface of the substrate, and then react with a monomer having a carboxyl group to react with the carboxyl on the surface of the substrate.
- a group is introduced (for example, see Japanese Patent Publication No. 1-54379, Japanese Patent Publication No. 1-54380, Japanese Patent Publication No. 1-54381). Specifically, first, the substrate and 1,3,5,7-tetramethylcyclotetrasiloxane are placed in a desiccator and deaerated with an aspirator. Next, after reacting at 80 ° C. for 16 hours, the substrate is taken out and dried at 120 ° C.
- the obtained substrate is immersed in ethanol, allylcarboxylic acid is added, an ethanol solution of chloroplatinic acid is added, and the mixture is stirred at 60 ° C. for 2 hours. After the reaction is completed, it is washed with ethanol and dried under reduced pressure.
- Examples of the material constituting the substrate include organic materials such as styrene-divinylbenzene copolymer; inorganic materials such as mica, talc, kaolin, alumina, titanium oxide, zinc oxide, and iron oxide.
- the monomer having a carboxyl group is not limited to allylcarboxylic acid, and may be a vinyl monomer having a carboxyl group, an acrylic monomer, or the like.
- a polymer having a functional group capable of generating a silanol group by hydrolysis hereinafter, A hydrolyzable polymer
- a hydrolyzable polymer a polymer having a functional group capable of generating a silanol group by hydrolysis
- the hydrolyzable polymer and alkoxysilane are hydrolyzed to produce silanol groups. Furthermore, the hydrolyzable polymer is crosslinked by dehydration condensation between silanol groups, and a crosslinked polymer layer into which the silanol groups are introduced is formed.
- water, acid or alkali is applied or heated.
- water, an acid, or an alkali you may apply
- the acid or alkali used for the hydrolysis is not particularly limited as long as it can be hydrolyzed, and two or more types can be mixed and used as an aqueous solution.
- a solution obtained by dissolving or dispersing a hydrolyzable polymer and alkoxysilane in an organic solvent can be used.
- the organic solvent include, but are not limited to, aliphatic hydrocarbons, aromatic hydrocarbons, chlorinated hydrocarbons, ether solvents, C 1-4 alcohols, C 1-4 aliphatic alcohol alcohol solvents, ethyl cellosolve, A cellosolve solvent such as butyl cellosolve, dioxane, methyl acetate, diformamide and the like may be mentioned, and two or more of them may be used in combination.
- the concentration of the hydrolyzable polymer in the coating solution is preferably 0.001 to 20% by weight, more preferably 0.1 to 5% by weight. If the concentration is less than 0.001% by weight, a sufficient effect may not be obtained by one treatment, and if it exceeds 20% by weight, the coatability may be inferior.
- the weight ratio of the hydrolyzable polymer to the alkoxysilane is preferably 0.01% to 20%, more preferably 0.2% to 5%.
- the weight ratio is less than 0.01% by weight, the strength of the crosslinked polymer layer may be insufficient, and when it exceeds 20%, the amount of silanol groups introduced into the crosslinked polymer layer may be insufficient. There is.
- the method for applying the coating solution is not particularly limited, and examples thereof include a dip coating method, a spray coating method, and a spin casting method.
- organic materials such as PP (polypropylene), polycarbonate, PET (polyethylene terephthalate), PEEK, fluororesin, polystyrene, vinyl chloride; gold, titanium, aluminum, iron, copper, stainless steel, alumina, Examples thereof include inorganic materials such as titanium oxide and zinc oxide.
- the hydrolyzable polymer is not particularly limited as long as it is a polymer having a functional group capable of generating a silanol group by hydrolysis.
- R 1 is a hydrogen atom or a methyl group
- R 2 is an alkylene group having 1 to 6 carbon atoms, preferably a propylene group
- R 3 , R 4 and R 5 are each independently And an alkoxyl group having 1 to 6 carbon atoms, preferably a methoxyl group or an ethoxyl group.
- a homopolymer or copolymer obtained by polymerizing the monomer (A-1) represented by formula (I) can be used. At this time, two or more monomers (A-1) may be used.
- R 6 is a hydrogen atom or a methyl group
- R 7 is a linear, branched or cyclic alkyl group having 1 to 18 carbon atoms, preferably an alkyl group having 1 to 6 carbon atoms, Particularly preferred is a methyl group.
- the monomer represented by (A-2) may be copolymerized. At this time, two or more monomers (A-2) may be used.
- R 8 is a hydrogen atom or a methyl group
- R 9 is an alkylene group having 1 to 6 carbon atoms, preferably an ethylene group, a propylene group or a 2-hydroxypropylene group
- X is formula
- R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 and R 18 are each independently a linear or branched alkyl having 1 to 6 carbon atoms. Group, preferably a methyl group.
- R 19 , R 20 , R 21 , R 22 , R 23 and R 24 are each independently a linear or branched alkyl group having 1 to 6 carbon atoms, preferably a methyl group, R 25 represents a linear or branched alkyl group having 1 to 6 carbon atoms, preferably a butyl group, and x is a positive integer.
- R 26 , R 27 , R 28 , R 29 , R 30 and R 31 are each independently a linear or branched alkyl group having 1 to 6 carbon atoms, preferably a methyl group
- R 32 is an alkylene group having 1 to 6 carbon atoms, preferably an ethylene group, a propylene group or a 2-hydroxypropylene group
- R 33 is a hydrogen atom or a methyl group
- y is a positive integer.
- the monomer represented by (A-3) may be copolymerized.
- the monomer (A-3) preferably has a molecular weight of 1,000 to 100,000, particularly preferably 2,000 to 20,000. At this time, two or more monomers (A-3) may be used.
- R 34 represents a hydrogen atom or a methyl group
- R 35 represents an alkylene group having 1 to 6 carbon atoms, preferably an ethylene group or a propylene group
- Y represents a general formula
- R 36 , R 37 and R 38 are each independently an alkyl group having 1 to 6 carbon atoms, preferably a methyl group, and Z ⁇ is a conjugate of a halide ion or an organic or inorganic acid. Ion.
- R 39 and R 40 are each independently an alkyl group having 1 to 6 carbon atoms, preferably a methyl group.
- the monomer represented by (A-4) may be copolymerized. At this time, two or more monomers (A-4) may be used.
- the polymer (A) when the polymer (A) is synthesized, at least one of the monomer (A-2), the monomer (A-3) and the monomer (A-4) may be copolymerized together with the monomer (A-1). Good.
- the content of the monomer (A-1) in all monomers used for synthesizing the polymer (A) is preferably 40 to 85% by weight.
- the content is less than 40% by weight, the crosslinking density is lowered and the effect of hydrophilization may not be sufficiently maintained.
- the content exceeds 85% by weight, the uniformity of the crosslinked polymer layer may be lowered. is there.
- the content of the monomer (A-2) in all monomers used when the polymer (A) is synthesized is preferably 1% by weight or more, and more preferably 10% by weight or more. When the content is less than 1% by weight, the water resistance of the crosslinked polymer layer may be lowered. Further, the content of the monomer (A-2) in all the monomers used when the polymer (A) is synthesized is preferably 75% by weight or less, and more preferably 60% by weight or less. When this content exceeds 75% by weight, the polymer (A) may be hardly soluble in the alcohol solvent.
- the content of the monomer (A-3) in all monomers used when the polymer (A) is synthesized is preferably 1% by weight or more, and more preferably 5% by weight or more. When the content is less than 1% by weight, the water resistance of the crosslinked polymer layer may be lowered. Furthermore, the content of the monomer (A-3) in all monomers used when the polymer (A) is synthesized is preferably 70% by weight or less, and more preferably 60% by weight or less. When this content exceeds less than 70% by weight, the polymer (A) may be hardly soluble in the alcohol solvent.
- the ratio of the weight of the monomer (A-4) to the total weight of the monomer (A-1), the monomer (A-2) and the monomer (A-3) is preferably 0.01 to 1.
- a more preferred range is 05 to 0.5.
- the number average molecular weight of the polymer (A) is not particularly limited as long as it has a polymerization degree equal to or higher than that of the oligomer, but is preferably 2000 to 150,000. When the number average molecular weight is less than 2000, the time for forming the crosslinked polymer layer may be long. When it exceeds 150,000, the viscosity of the coating solution increases, and the coating property and workability may be inferior.
- R 1 represents an alkyl group having 1 to 22 carbon atoms or a phenyl group, preferably a methyl group.
- a homopolymer or copolymer having a structural unit (B-1) represented by the formula (hereinafter referred to as polymer (B)) can be used. At this time, the polymer (B) may have two or more structural units (B-1).
- polymer (B) is a general formula
- the content of the structural unit (B-1) in the polymer (B) is preferably 1 to 90% by weight. When this content is less than 1% by weight, the crosslinking density is lowered and the effect of hydrophilization may not be sufficiently maintained. When it exceeds 90% by weight, the uniformity of the crosslinked polymer layer may be lowered. is there.
- the content of the structural unit (B-2) in the polymer (B) is preferably 10 to 99% by weight.
- the uniformity of the crosslinked polymer layer may be lowered.
- the content is less than 99% by weight, the crosslinking density is lowered and the effect of hydrophilization is not sufficiently sustained. There is.
- the number average molecular weight of the polymer (B) is not particularly limited as long as it has a polymerization degree equal to or higher than that of the oligomer, but is preferably 2000 to 500,000. When the number average molecular weight is less than 2,000, the time for forming the crosslinked polymer layer may be long. When the number average molecular weight exceeds 500,000, the viscosity of the coating solution becomes high and the coating property and workability may be inferior.
- the polymer (A) and the polymer (B) may be used in combination, or a hydrolyzable polymer and a non-hydrolyzable polymer may be used in combination.
- a non-hydrolyzable polymer The polymer (A), polymer (B), etc. which do not have a functional group which can produce
- Examples of a method for introducing silanol groups onto the surface of a substrate include a method of forming a film containing a silanol group-containing silicone resin by applying a coating solution containing a silicone resin to the substrate.
- the film containing a silicone resin having a silanol group preferably has a water contact angle of 3 to 8 °. It is difficult to form a film having a water contact angle of less than 3 °. When a film having a water contact angle of more than 8 ° is formed, phosphorylcholine-like groups cannot be introduced at high density on the surface of the substrate. is there.
- the silicone resin contained in the coating solution is not particularly limited, but the general formula (R 1 O) n Si (R 2 ) 4-n Wherein R 1 and R 2 are each independently an alkyl group having 1 to 8 carbon atoms, n is an integer of 1 to 4, and when n is 1 or 2, a plurality of R 2 may be the same or different, and when n is 2 or 3, a plurality of R 1 may be the same or different.
- the resin obtained by condensing after hydrolyzing the alkoxysilane represented by these is mentioned, You may use 2 or more types together.
- the silicone resin having a silanol group contained in the film having a water contact angle of 3 to 8 ° may be the same as or different from the silicone resin contained in the coating solution.
- silicone resins contained in the coating solution examples include Fressera R (manufactured by Panasonic Electric Works Co., Ltd.).
- the organic solvent contained in the coating solution is not particularly limited, but aliphatic hydrocarbons, aromatic hydrocarbons, chlorinated hydrocarbons, ether solvents, aliphatic alcohol alcohols having 1 to 4 carbon atoms and 1 to 4 carbon atoms.
- examples thereof include a solvent, a cellosolve solvent such as ethyl cellosolve and butyl cellosolve, dioxane, methyl acetate, diformamide and the like, and two or more of them may be used in combination.
- the concentration of the silicone resin in the coating solution is preferably 0.001 to 1% by weight, more preferably 0.1 to 1% by weight. When the concentration is less than 0.001% by weight, a uniform film may not be formed, and when it exceeds 20% by weight, coatability and the like may be deteriorated.
- the method for applying the coating solution is not particularly limited, and examples thereof include a dip coating method, a spray coating method, and a spin casting method.
- Organic materials such as a polycarbonate, PET (polyethylene terephthalate), a polystyrene, an acrylic resin; Gold, titanium, aluminum, iron, copper, stainless steel, an alumina, a titanium oxide, a zinc oxide, etc. Inorganic materials and the like.
- the surface modifier preferably has a molecular weight of 255 to 549, more preferably 255 to 283.
- phosphorylcholine-like groups can be introduced at high density onto the surface of the substrate, and the adsorption of biological substances can be suppressed.
- the functional group having reactivity with the reactive functional group of the surface modifier is not particularly limited.
- examples of the functional group having reactivity with an amino group and a hydroxyl group include a carboxyl group and an aldehyde group, and a carboxyl group is preferable because of high reactivity.
- examples of functional groups having reactivity with aldehyde groups and carboxyl groups include amino groups and hydroxyl groups, but amino groups are preferred because of their high reactivity.
- examples of the functional group capable of generating a silanol group by hydrolysis or a functional group having reactivity with the silanol group include a functional group or silanol group capable of generating a silanol group by hydrolysis. It is done.
- the reactive functional group is preferably bonded to a phosphorylcholine-like group via a spacer.
- the spacer is not particularly limited, and examples thereof include an alkylene group having at least one methylene group, oxyethylene group, and amino group.
- the surface modifier having an amino group is not particularly limited, and examples thereof include compounds disclosed in JP-A-2006-7203 and JP-A-2006-7204. 2)
- R 1 , R 2 and R 3 each independently represents an alkyl group having 1 to 6 carbon atoms, A represents an imino group, an ester bond or an amide bond, and B represents a carbon number.
- the compound represented by these is preferable.
- the compound represented by the general formula (2) includes, for example, a compound having an amino group after synthesizing a phosphorylcholine derivative having an aldehyde group by oxidizing glycerophosphorylcholine with periodic acid. It can be synthesized by condensation. Further, when A is an amide bond or an ester bond, the compound represented by the general formula (2) synthesizes a phosphorylcholine derivative having a carboxyl group by, for example, a method of oxidizing glycerophosphorylcholine with periodic acid and ruthenium trichloride. Then, it can be synthesized by condensing with a compound having an amino group or a hydroxyl group.
- the compound represented by the general formula (2) is obtained by, for example, oxidizing glycerophosphorylcholine with permanganic acid and hydrochloric acid to synthesize a phosphorylcholine derivative having a carboxyl group, It can be synthesized by condensation with a compound having a group or a hydroxyl group.
- L- ⁇ -glycerophosphorylcholine represented by the formula (commercially available product) is dissolved in distilled water, cooled in an ice water bath, sodium periodate is added, and the mixture is stirred for 5 hours. Further, after concentration under reduced pressure and drying under reduced pressure, extraction with methanol gives structural formula (2)
- ethylenediamine is added to a methanol solution of the phosphorylcholine derivative represented by the structural formula (4), and then a triazine-type dehydrating condensing agent (DMT-MM) is added and stirred for 3 hours. Further, the precipitate is removed by filtration, concentrated under reduced pressure, and dried under reduced pressure to obtain the structural formula (5).
- DMT-MM triazine-type dehydrating condensing agent
- the surface modifier B represented by is obtained.
- ethylenediamine is added to a methanol solution of the phosphorylcholine derivative represented by the structural formula (4), and then a triazine-type dehydrating condensing agent (DMT-MM) is added and stirred for 3 hours.
- DMT-MM triazine-type dehydrating condensing agent
- the surface modifier B represented by Structural Formula (5) is obtained by removing the precipitate by filtration, performing vacuum concentration and drying under reduced pressure.
- the substrate having a carboxyl group on the surface and the surface modifier having an amino group are condensed by a general reaction to form an amide bond. Specifically, the substrate is dipped in a solution of N-hydroxysuccinimide and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide so that the carboxyl groups of the particles are active esterified, and then the surface modifier is added. Add.
- a substrate having an aldehyde group on the surface and a surface modifier having an amino group are condensed by a general reaction to form an imino bond. Specifically, after the substrate and the surface modifier are left in methanol at room temperature for 6 hours, sodium cyanotrihydroborate is added at 0 ° C. and heated and stirred overnight.
- a protic solvent such as water, ethanol, 2-propanol or the like can be used as the reaction solvent, but the introduction rate tends to be high when methanol is used.
- the surface modifier having a hydroxyl group is not particularly limited, and examples thereof include L- ⁇ -glycerophosphorylcholine.
- Examples of a method for producing a surface modifier having a hydroxyl group include a method of reducing the phosphorylcholine derivative represented by the structural formula (2) or the phosphorylcholine derivative represented by the structural formula (4) with sodium borohydride or the like. Can be mentioned.
- the substrate having a carboxyl group on the surface and the surface modifier having a hydroxyl group are condensed by a general reaction to form an ester bond. Specifically, the substrate is immersed after activating the hydroxyl group of the surface modifier using cyanogen bromide.
- a substrate having an aldehyde group on the surface and a surface modifier having a hydroxyl group are added by a general reaction to form an acetal bond. Specifically, after the substrate and the surface modifier are left in methanol at room temperature for 6 hours, sodium cyanotrihydroborate is added at 0 ° C. and heated and stirred overnight.
- a protic solvent such as water, ethanol, 2-propanol or the like can be used as the reaction solvent, but the introduction rate tends to be high when methanol is used.
- the surface modifier having an aldehyde group is not particularly limited, and examples thereof include compounds disclosed in JP-A-2006-11383.
- a substrate having a hydroxyl group on the surface and a surface modifier having an aldehyde group are added by a general reaction to form an acetal bond. Specifically, after the substrate and the surface modifier are left in methanol at room temperature for 6 hours, sodium cyanotrihydroborate is added at 0 ° C. and heated and stirred overnight.
- a protic solvent such as water, ethanol, 2-propanol or the like can be used as the reaction solvent, but the introduction rate tends to be high when methanol is used.
- the substrate having an amino group on the surface and the surface modifier having an aldehyde group are condensed by a general reaction to form an imino bond. Specifically, after the substrate and the surface modifier are left in methanol at room temperature for 6 hours, sodium cyanotrihydroborate is added at 0 ° C. and heated and stirred overnight.
- a protic solvent such as water, ethanol, 2-propanol or the like can be used as the reaction solvent, but the introduction rate tends to be high when methanol is used.
- the surface modifier having a carboxyl group is not particularly limited, and examples thereof include compounds disclosed in JP-A-2006-11381.
- the substrate having a hydroxyl group on the surface and the surface modifier having a carboxyl group are condensed by a general reaction to form an ester bond. Specifically, the substrate is immersed after activating the hydroxyl group of the surface modifier using cyanogen bromide.
- the substrate having an amino group on the surface and the surface modifying agent having a carboxyl group form an amide bond by condensing the amino group and the carboxyl group by a general reaction.
- the surface modifier is immersed in a solution of N-hydroxysuccinimide and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide to convert the carboxyl group into an active ester, and then the substrate is immersed.
- Examples of the functional group capable of generating a silanol group by hydrolysis include a hydrosilyl group, an alkoxysilyl group, a halosilyl group, an acyloxysilyl group, an aminosilyl group, and the like. From this point, an alkoxysilyl group or a hydrosilyl group having 1 to 6 carbon atoms is preferable.
- the functional group capable of generating a silanol group by hydrolysis and / or a surface modifier having a silanol group is not particularly limited, and examples thereof include compounds disclosed in JP-A-2006-11380. It is done.
- the acid or alkali used for the hydrolysis is not particularly limited as long as it can be hydrolyzed, and two or more types can be mixed and used as an aqueous solution.
- a solution obtained by dissolving or dispersing a surface modifying agent in an organic solvent can be used.
- the organic solvent include aliphatic hydrocarbons, aromatic hydrocarbons, chlorinated hydrocarbons, ether solvents, alcohol solvents such as aliphatic alcohols having 1 to 4 carbon atoms and 1 to 4 carbon atoms, ethyl cellosolve, butyl cellosolve, and the like.
- alcohol solvents such as aliphatic alcohols having 1 to 4 carbon atoms and 1 to 4 carbon atoms, ethyl cellosolve, butyl cellosolve, and the like.
- cellosolve solvents dioxane, methyl acetate, diformamide, and the like.
- the concentration of the surface modifier in the coating solution is preferably from 0.1 to 30% by weight, more preferably from 1 to 10% by weight.
- concentration is less than 0.1% by weight, the surface modifier may not be sufficiently applied by one application, and when it exceeds 30% by weight, the coatability may be inferior.
- the method for applying the coating solution is not particularly limited, and examples thereof include a dip coating method, a spray coating method, and a spin casting method.
- the biochip of the present invention is manufactured by reacting the surface-modified substrate of the present invention with a ligand having a functional group having reactivity with the reactive functional group of the substrate.
- the ligand and phosphorylcholine-like group can be introduced at a high density on the surface of the substrate.
- the functional group having reactivity with the reactive functional group of the ligand is not particularly limited.
- examples of the functional group having reactivity with an amino group and a hydroxyl group include a carboxyl group and an aldehyde group, and a carboxyl group is preferable because of high reactivity.
- examples of functional groups having reactivity with aldehyde groups and carboxyl groups include amino groups and hydroxyl groups, but amino groups are preferred because of their high reactivity.
- examples of the functional group capable of generating a silanol group by hydrolysis or a functional group having reactivity with the silanol group include a functional group or silanol group capable of generating a silanol group by hydrolysis. It is done.
- Examples of the functional group capable of generating a silanol group by hydrolysis include a hydrosilyl group, an alkoxysilyl group, a halosilyl group, an acyloxysilyl group, and an aminosilyl group. From the viewpoint of stability, reactivity, etc., carbon An alkoxysilyl group or hydrosilyl group having a number of 1 to 6 is preferred.
- the ligand and the reactive functional group are preferably bonded via a spacer.
- the spacer is not particularly limited, and examples thereof include an alkylene group having at least one methylene group, oxyethylene group, and amino group.
- the ligand is not particularly limited, but various antibodies such as IgG, IgM, IgA, IgD, IgE, IgY; antigens such as proteins and polysaccharides; enzymes such as glutathione-S-transferase; substrates such as glutathione; hormone receptors, Receptors such as cytokine receptors; peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin; chelating compounds such as nitrilotriacetic acid; various metals such as Ni 2+ , Co 2+ , Cu 2+ , Zn 2+ , Fe 3+ And ions.
- various antibodies such as IgG, IgM, IgA, IgD, IgE, IgY; antigens such as proteins and polysaccharides; enzymes such as glutathione-S-transferase; substrates such as glutathione; hormone receptors, Receptors such as cytokin
- the substrate having an aldehyde group on the surface and the amino group of the protein are condensed by a general reaction to form an imino bond. Specifically, after leaving the substrate and protein in methanol at room temperature for 6 hours, sodium cyanotrihydroborate is added at 0 ° C. and heated and stirred overnight.
- a protic solvent such as water, ethanol, 2-propanol or the like can be used as the reaction solvent, but the introduction rate tends to be high when methanol is used.
- the substrate having a carboxyl group on the surface and the amino group of the protein are condensed by a general reaction to form an amide bond. Specifically, the substrate is immersed in a solution of N-hydroxysuccinimide and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide to convert the carboxyl group of the substrate into an active ester, and then a protein is added.
- the substrate having an amino group on the surface and the amino group of the protein are condensed through glutaraldehyde by a general reaction to form an imino bond. Specifically, glutaraldehyde is reacted with a substrate (or protein) and then reacted with the protein (or substrate).
- the substrate having a hydroxyl group on the surface and the carboxyl group of the protein are condensed by a general reaction to form an ester bond.
- the protein is added after activating the hydroxyl group of the substrate using cyanogen bromide.
- the functional group reactive to the reactive functional group of the ligand may be the same as or different from the functional group reactive to the reactive functional group of the surface modifier. May be.
- the method for producing a biochip of the present invention comprises a step of reacting a substrate having a reactive functional group on a surface with a ligand having a functional group reactive to the reactive functional group, and a substrate reacted with the ligand.
- R 1 , R 2 and R 3 are each independently an alkyl group having 1 to 6 carbon atoms, m is an integer of 2 to 6 and n is 1 or 2).
- Such a biochip can selectively capture a target substance by being immersed in a liquid sample containing the target substance that specifically binds to a ligand.
- a biochip A protein chip, a DNA chip, etc. are mentioned.
- the biochip can be applied to biosensors such as blood glucose sensors, BOD sensors, and DNA sensors.
- the blood glucose sensor has a sensor chip with glucose oxidase immobilized on its surface, and quantifies the hydrogen peroxide produced by the oxidation of glucose using electrochemical analysis or colorimetric analysis. The concentration can be measured.
- Example 1 The well of a 96-well plate made of polystyrene was washed with 2-propanol, then immersed in a mixed solution consisting of 0.21 ml of 2-propanol and 0.09 ml of Fresella R (manufactured by Panasonic Electric Works), and dried at room temperature for 1 hour. Silanol groups were introduced on the surface of the well.
- N-hydroxysuccinimide and 3 mg of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide were dissolved in 0.3 ml of ultrapure water, and then a solution adjusted to pH 4.5 with hydrochloric acid was added to the well. In addition, the reaction was allowed to proceed at room temperature for 1 hour, whereby the carboxyl group introduced to the surface of the well was active esterified. Next, a solution prepared by dissolving 1 mg of anti-human albumin antibody in 0.2 ml of phosphate buffered saline (PBS) was added to the well and reacted at room temperature for 1 hour to introduce the anti-human albumin antibody onto the surface of the well.
- PBS phosphate buffered saline
- Example 1 A biochip was obtained in the same manner as in Example 1 except that ethanol groups were used instead of the surface modifier B and hydroxyl groups were introduced into the well surfaces.
- Example 1 As a result, it can be seen that the biochips of Example 1 and Comparative Example 1 have the same absorbance (signal) at a wavelength of 450 nm (see FIG. 1). From this, it is presumed that the amount of the HRP-labeled anti-human albumin antibody immobilized through human albumin is comparable to the anti-human albumin antibody introduced on the surface of the well.
- the biochip of Example 1 has an absorbance (noise) at a wavelength of 450 nm that is about 1 ⁇ 2 that of the biochip of Comparative Example 1 (see FIG. 1). From this, the amount of the HRP-labeled anti-human albumin antibody immobilized on the surface of the well of the biochip of Example 1 is estimated to be about 1 ⁇ 2 that of the biochip of Comparative Example 1. For this reason, the biochip of Example 1 is considered to be highly effective in suppressing protein adsorption because phosphorylcholine groups are introduced at a high density on the surface of the well.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Paints Or Removers (AREA)
Abstract
Description
で表される基を有する化合物を反応させることにより製造されていることを特徴とする。
で表される基を有する化合物を反応させる工程を有することを特徴とする。
で表されるホスホリルコリン類似基を有する表面改質剤を反応させることにより製造されている。これにより、基板の表面にホスホリルコリン類似基を高密度で導入することができる。その結果、生体物質の吸着を抑制することが可能な表面改質基板が得られる。
で表されるモノマー(A-1)を重合することにより得られるホモポリマー又はコポリマー(以下、ポリマー(A)という)を用いることができる。このとき、モノマー(A-1)を二種以上用いてもよい。
で表されるモノマー(A-2)を共重合してもよい。このとき、モノマー(A-2)を二種以上用いてもよい。
で表される官能基(X-1)、一般式
で表される官能基(X-2)又は一般式
で表される官能基(X-3)である。)
で表されるモノマー(A-3)を共重合してもよい。なお、Xが官能基(X-2)又は(X-3)である場合、モノマー(A-3)は、分子量が1000~100000であることが好ましく、2000~20000が特に好ましい。このとき、モノマー(A-3)を二種以上用いてもよい。
で表される官能基(Y-1)又は一般式
で表される官能基(Y-2)である。)
で表されるモノマー(A-4)を共重合してもよい。このとき、モノマー(A-4)を二種以上用いてもよい。
で表される構成単位(B-1)を有するホモポリマー又はコポリマー(以下、ポリマー(B)という)を用いることができる。このとき、ポリマー(B)は、構成単位(B-1)を二種以上有してもよい。
で表される構成単位(B-2)を有してもよい。このとき、ポリマー(B)は、構成単位(B-2)を二種以上有してもよい。
(R1O)nSi(R2)4-n
(式中、R1及びR2は、それぞれ独立に、炭素数が1~8のアルキル基であり、nは、1~4の整数であり、nが1又は2である場合、複数のR2は、同一であっても異なっていてもよく、nが2又は3である場合、複数のR1は、同一であっても異なっていてもよい。)
で表されるアルコキシシランを加水分解した後、縮合することにより得られる樹脂が挙げられ、二種以上併用してもよい。このとき、水の接触角が3~8°である膜に含まれるシラノール基を有するシリコーン樹脂は、塗布液に含まれるシリコーン樹脂と同一であってもよいし、異なっていてもよい。
アミノ基を有する表面改質剤としては、特に限定されないが、例えば、特開2006-7203号公報、特開2006-7204号公報に開示されている化合物等が挙げられるが、中でも、一般式(2)
で表される化合物が好ましい。
まず、構造式(1)
まず、L-α-グリセロホスホリルコリンの水溶液を氷水浴中で冷却した後、過ヨウ素酸ナトリウム及び三塩化ルテニウムを添加し、3時間攪拌する。次に、メタノールを添加して、さらに30分間攪拌した後、ろ過により沈殿を除去し、減圧濃縮及び減圧乾燥を行うことにより、構造式(4)
まず、L-α-グリセロホスホリルコリンを氷水浴中で冷却しながら、塩酸に溶解させた後、過マンガン酸カリウムを添加し、3時間攪拌する。次に、メタノールを添加して、さらに30分間攪拌した後、ろ過により沈殿を除去し、減圧濃縮及び減圧乾燥を行うことにより、構造式(4)で表されるホスホリルコリン誘導体が得られる。
ヒドロキシル基を有する表面改質剤としては、特に限定されないが、例えば、L-α-グリセロホスホリルコリン等が挙げられる。ヒドロキシル基を有する表面改質剤の製造方法としては、例えば、構造式(2)で表されるホスホリルコリン誘導体又は構造式(4)で表されるホスホリルコリン誘導体を水素化ホウ素ナトリウム等により還元する方法が挙げられる。
アルデヒド基を有する表面改質剤としては、特に限定されないが、例えば、特開2006-11383号公報に開示されている化合物等が挙げられる。
カルボキシル基を有する表面改質剤としては、特に限定されないが、例えば、特開2006-11381号公報に開示されている化合物等が挙げられる。
加水分解によりシラノール基を生成することが可能な官能基としては、ヒドロシリル基、アルコキシシリル基、ハロシリル基、アシルオキシシリル基、アミノシリル基等が挙げられるが、親水化剤の安定性、反応性等の点から、炭素数が1~6のアルコキシシリル基又はヒドロシリル基が好ましい。加水分解によりシラノール基を生成することが可能な官能基及び/又はシラノール基を有する表面改質剤としては、特に限定されないが、例えば、特開2006-11380号公報に開示されている化合物が挙げられる。
で表されるホスホリルコリン類似基を有する表面改質剤を反応させる工程を有する。これにより、基板の表面にリガンド及びホスホリルコリン類似基をさらに高密度で導入することができる。その結果、目的物質の捕捉効率に優れると共に、目的物質以外の生体物質の吸着を抑制することが可能なバイオチップが得られる。
ポリスチレン製の96ウェルプレートのウェルを2-プロパノールで洗浄した後、2-プロパノール0.21ml及びフレッセラR(パナソニック電工社製)0.09mlからなる混合液に浸漬させ、室温で1時間乾燥させ、ウェルの表面にシラノール基を導入した。
表面改質剤Bの代わりに、エタノールアミン用いて、ウェルの表面にヒドロキシル基を導入した以外は、実施例1と同様にして、バイオチップを得た。
実施例1及び比較例1のバイオチップのウェルに、ヒトアルブミンの1mg/mlPBS溶液0.1mlを加え、室温で1時間反応させた。次に、ウェルをPBSで洗浄した後、HRP標識抗ヒトアルブミン抗体の1μg/mlPBS溶液0.1mlを加え、室温で1時間反応させた。さらに、ウェルをPBSで洗浄した後、基質TMBZを用いて発色試験を行い、波長が450nmの吸光度を測定した。その結果、実施例1及び比較例1のバイオチップは、波長が450nmの吸光度(シグナル)が同程度であることがわかる(図1参照)。このことから、ウェルの表面に導入された抗ヒトアルブミン抗体に、ヒトアルブミンを介して、固定化されたHRP標識抗ヒトアルブミン抗体の量が同程度であることが推測される。
実施例1及び比較例1のバイオチップのウェルに、PBS1mlを加え、室温で1時間保管した。次に、ウェルをPBSで洗浄した後、HRP標識抗ヒトアルブミン抗体の1μg/mlPBS溶液0.1mlを加え、室温で1時間反応させた。さらに、ウェルをPBSで洗浄した後、基質TMBZを用いて発色試験を行い、波長が450nmの吸光度を測定した。その結果、実施例1のバイオチップは、波長が450nmの吸光度(ノイズ)が、比較例1のバイオチップの1/2程度であることがわかる(図1参照)。このことから、実施例1のバイオチップは、ウェルの表面に固定化されたHRP標識抗ヒトアルブミン抗体の量が、比較例1のバイオチップの1/2程度であることが推測される。このため、実施例1のバイオチップは、ウェルの表面にホスホリルコリン基が高密度で導入されているため、タンパク質の吸着を抑制する効果が高いと考えられる。
Claims (7)
- 前記反応性官能基は、アミノ基、ヒドロキシル基、アルデヒド基、カルボキシル基、加水分解によりシラノール基を生成することが可能な官能基及びシラノール基からなる群より選択される一種以上であることを特徴とする請求項1に記載の表面改質基板。
- 請求項1に記載の表面改質基板に、前記反応性官能基に対して反応性を有する官能基を有するリガンドを反応させることにより製造されていることを特徴とするバイオチップ。
- 請求項4に記載のバイオチップの製造方法を用いて製造されていることを特徴とするバイオチップ。
- 請求項3又は5に記載のバイオチップを有することを特徴とするバイオセンサ。
- 請求項6に記載のバイオセンサを用いて、前記リガンドに対して特異的に結合する物質を分析することを特徴とする分析方法。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10748721A EP2405267A1 (en) | 2009-03-02 | 2010-03-01 | Surface-modified base plate, biochip and process for producing the biochip |
| CN2010800079193A CN102317782A (zh) | 2009-03-02 | 2010-03-01 | 表面改性基板以及生物芯片及其制造方法 |
| US13/148,680 US20120034709A1 (en) | 2009-03-02 | 2010-03-01 | surface modified substrate, biotip and a method for producing thereof |
| JP2011502749A JP5391265B2 (ja) | 2009-03-02 | 2010-03-01 | バイオチップの製造方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009-047518 | 2009-03-02 | ||
| JP2009047518 | 2009-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2010101126A1 true WO2010101126A1 (ja) | 2010-09-10 |
Family
ID=42709683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2010/053278 Ceased WO2010101126A1 (ja) | 2009-03-02 | 2010-03-01 | 表面改質基板並びにバイオチップ及びその製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120034709A1 (ja) |
| EP (1) | EP2405267A1 (ja) |
| JP (1) | JP5391265B2 (ja) |
| KR (1) | KR20110137292A (ja) |
| CN (1) | CN102317782A (ja) |
| WO (1) | WO2010101126A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012081470A1 (ja) * | 2010-12-13 | 2012-06-21 | 株式会社資生堂 | 細胞凝集塊の形成方法 |
| US20120156696A1 (en) * | 2009-06-15 | 2012-06-21 | Shiseido Company, Ltd. | container for forming a cell aggregate and a method for forming a cell aggregate |
| JP2012229180A (ja) * | 2011-04-27 | 2012-11-22 | National Institute Of Advanced Industrial Science & Technology | ホスホリルコリン−シラン化合物表面修飾材料 |
| WO2023033012A1 (ja) * | 2021-08-31 | 2023-03-09 | 日油株式会社 | ホスホリルコリン基と水酸基を有するポリジメチルシロキサン含有モノマー |
| WO2023033013A1 (ja) * | 2021-08-31 | 2023-03-09 | 日油株式会社 | ホスホリルコリン基と水酸基を有するポリジメチルシロキサン含有モノマー |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE112019001895T5 (de) * | 2018-04-10 | 2020-12-24 | AGC Inc. | Medizinische vorrichtung |
Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0154379B2 (ja) | 1984-11-26 | 1989-11-17 | Shiseido Co Ltd | |
| JPH0154381B2 (ja) | 1985-07-29 | 1989-11-17 | Shiseido Co Ltd | |
| JPH0763728A (ja) * | 1993-08-16 | 1995-03-10 | Hewlett Packard Co <Hp> | キャピラリ電気泳動による成分分離方法と電気泳動に用いられるキャピラリ管と電気泳動装置 |
| JPH11302129A (ja) | 1997-05-30 | 1999-11-02 | Shiseido Co Ltd | 毛髪処理用組成物及び毛髪処理方法 |
| JP2000279512A (ja) | 1999-03-30 | 2000-10-10 | Nof Corp | 医療用材料および製造方法 |
| JP2002098676A (ja) | 2000-09-22 | 2002-04-05 | Kazuhiko Ishihara | 分離材及び分離・回収方法 |
| WO2005054262A1 (ja) * | 2003-12-02 | 2005-06-16 | Shiseido Company, Ltd. | ホスホリルコリン基含有化合物及び該化合物からなる表面改質剤 |
| JP2006011380A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 眼用レンズ材料及びその製造方法 |
| JP2006008987A (ja) * | 2004-05-21 | 2006-01-12 | Shiseido Co Ltd | 素材の表面改質方法 |
| JP2006007204A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | アフィニティー粒子及びアフィニティー分離方法 |
| JP2006007203A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | アフィニティー粒子及びアフィニティー分離方法 |
| JP2006011381A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 眼用レンズ材料及びその製造方法 |
| JP2006011383A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 蛋白質吸着防止眼用レンズ材料及びその製造方法 |
| JP2006322717A (ja) * | 2005-05-17 | 2006-11-30 | Kazuhiko Ishihara | センサチップおよびその製造方法 |
| JP2007022886A (ja) * | 2005-07-20 | 2007-02-01 | Univ Of Tokyo | ポリマー被覆粒子 |
| JP2007298373A (ja) * | 2006-04-28 | 2007-11-15 | Univ Of Tokyo | ポリマー膜固定化基板、その製造方法、及びその用途 |
| JP2008143874A (ja) * | 2006-12-13 | 2008-06-26 | Shiseido Co Ltd | ホスホリルコリン基含有シラン化合物の製造方法 |
| JP2009047518A (ja) | 2007-08-17 | 2009-03-05 | Sun Plastics Co Ltd | 電気泳動解析による赤血球表面電位測定方法及びその装置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798261A (en) * | 1989-10-31 | 1998-08-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Distributed pore chemistry in porous organic polymers |
| GB9004881D0 (en) * | 1990-03-05 | 1990-05-02 | Biocompatibles Ltd | Method of improving the ocular of synthetic polymers haemo and biocompatibility |
| US5726061A (en) * | 1996-10-08 | 1998-03-10 | Smithkline Beechum Corporation | Method of diagnosing and monitoring colorectal cancer |
| US20060160089A1 (en) * | 2003-03-31 | 2006-07-20 | Kanagawa Academy Of Science And Technology | Fixing agents, method of fixing substance with the same, and substrate having sustance fixed thereto with the same |
| CN101513606A (zh) * | 2004-05-24 | 2009-08-26 | 株式会社资生堂 | 亲和颗粒和亲和分离方法 |
| JP2006308307A (ja) * | 2005-04-26 | 2006-11-09 | Toyo Kohan Co Ltd | 生体関連分子の非特異的吸着を阻害する方法および生体関連分子検出用キット |
| KR100738083B1 (ko) * | 2005-12-20 | 2007-07-12 | 삼성전자주식회사 | 마이크로어레이용 기판 및 그의 제조방법 |
| JP4191225B2 (ja) * | 2007-01-18 | 2008-12-03 | 株式会社資生堂 | 表面改質方法及び表面改質材料 |
| US20110021756A1 (en) * | 2008-03-19 | 2011-01-27 | Katsuyuki Maeno | Method of manufacturing an affinity particle, affinity particle, and separation method |
-
2010
- 2010-03-01 US US13/148,680 patent/US20120034709A1/en not_active Abandoned
- 2010-03-01 CN CN2010800079193A patent/CN102317782A/zh active Pending
- 2010-03-01 WO PCT/JP2010/053278 patent/WO2010101126A1/ja not_active Ceased
- 2010-03-01 KR KR1020117018684A patent/KR20110137292A/ko not_active Ceased
- 2010-03-01 JP JP2011502749A patent/JP5391265B2/ja not_active Expired - Fee Related
- 2010-03-01 EP EP10748721A patent/EP2405267A1/en not_active Withdrawn
Patent Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0154379B2 (ja) | 1984-11-26 | 1989-11-17 | Shiseido Co Ltd | |
| JPH0154381B2 (ja) | 1985-07-29 | 1989-11-17 | Shiseido Co Ltd | |
| JPH0154380B2 (ja) | 1985-07-29 | 1989-11-17 | Shiseido Co Ltd | |
| JPH0763728A (ja) * | 1993-08-16 | 1995-03-10 | Hewlett Packard Co <Hp> | キャピラリ電気泳動による成分分離方法と電気泳動に用いられるキャピラリ管と電気泳動装置 |
| JPH11302129A (ja) | 1997-05-30 | 1999-11-02 | Shiseido Co Ltd | 毛髪処理用組成物及び毛髪処理方法 |
| JP2000279512A (ja) | 1999-03-30 | 2000-10-10 | Nof Corp | 医療用材料および製造方法 |
| JP2002098676A (ja) | 2000-09-22 | 2002-04-05 | Kazuhiko Ishihara | 分離材及び分離・回収方法 |
| WO2005054262A1 (ja) * | 2003-12-02 | 2005-06-16 | Shiseido Company, Ltd. | ホスホリルコリン基含有化合物及び該化合物からなる表面改質剤 |
| JP2006008987A (ja) * | 2004-05-21 | 2006-01-12 | Shiseido Co Ltd | 素材の表面改質方法 |
| JP2006011380A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 眼用レンズ材料及びその製造方法 |
| JP2006007204A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | アフィニティー粒子及びアフィニティー分離方法 |
| JP2006007203A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | アフィニティー粒子及びアフィニティー分離方法 |
| JP2006011381A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 眼用レンズ材料及びその製造方法 |
| JP2006011383A (ja) | 2004-05-24 | 2006-01-12 | Shiseido Co Ltd | 蛋白質吸着防止眼用レンズ材料及びその製造方法 |
| JP2006322717A (ja) * | 2005-05-17 | 2006-11-30 | Kazuhiko Ishihara | センサチップおよびその製造方法 |
| JP2007022886A (ja) * | 2005-07-20 | 2007-02-01 | Univ Of Tokyo | ポリマー被覆粒子 |
| JP2007298373A (ja) * | 2006-04-28 | 2007-11-15 | Univ Of Tokyo | ポリマー膜固定化基板、その製造方法、及びその用途 |
| JP2008143874A (ja) * | 2006-12-13 | 2008-06-26 | Shiseido Co Ltd | ホスホリルコリン基含有シラン化合物の製造方法 |
| JP2009047518A (ja) | 2007-08-17 | 2009-03-05 | Sun Plastics Co Ltd | 電気泳動解析による赤血球表面電位測定方法及びその装置 |
Non-Patent Citations (4)
| Title |
|---|
| COLLOIDS AND SURFACES A: PHYSICOCHEM. ENG. ASPECTS, vol. 195, 2001, pages 81 - 95 |
| MACROMOL. CHEM. PHYS., vol. 200, 1999, pages 989 - 996 |
| See also references of EP2405267A4 |
| SURFACE AND COATINGS TECHNOLOGY, vol. 116-119, 1999, pages 802 - 807 |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120156696A1 (en) * | 2009-06-15 | 2012-06-21 | Shiseido Company, Ltd. | container for forming a cell aggregate and a method for forming a cell aggregate |
| US9347031B2 (en) * | 2009-06-15 | 2016-05-24 | Shiseido Company, Ltd. | Container for forming a cell aggregate and a method for forming a cell aggregate |
| WO2012081470A1 (ja) * | 2010-12-13 | 2012-06-21 | 株式会社資生堂 | 細胞凝集塊の形成方法 |
| JP2012187097A (ja) * | 2010-12-13 | 2012-10-04 | Shiseido Co Ltd | 細胞凝集塊の形成方法 |
| JP2012229180A (ja) * | 2011-04-27 | 2012-11-22 | National Institute Of Advanced Industrial Science & Technology | ホスホリルコリン−シラン化合物表面修飾材料 |
| WO2023033012A1 (ja) * | 2021-08-31 | 2023-03-09 | 日油株式会社 | ホスホリルコリン基と水酸基を有するポリジメチルシロキサン含有モノマー |
| WO2023033013A1 (ja) * | 2021-08-31 | 2023-03-09 | 日油株式会社 | ホスホリルコリン基と水酸基を有するポリジメチルシロキサン含有モノマー |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2010101126A1 (ja) | 2012-09-10 |
| US20120034709A1 (en) | 2012-02-09 |
| JP5391265B2 (ja) | 2014-01-15 |
| CN102317782A (zh) | 2012-01-11 |
| EP2405267A4 (en) | 2012-01-11 |
| KR20110137292A (ko) | 2011-12-22 |
| EP2405267A1 (en) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5391265B2 (ja) | バイオチップの製造方法 | |
| EP1577360B1 (en) | Method of modifying surface of material | |
| JP5280664B2 (ja) | 表面改質方法及び表面改質材料 | |
| US12343452B2 (en) | Fluorosilinated liquid-infused surfaces with embedded biomolecules, methods of making and uses thereof | |
| Miyachi et al. | Application of polymer‐embedded proteins to fabrication of DNA array | |
| JP5421900B2 (ja) | アフィニティー粒子の製造方法 | |
| Lunelli et al. | A new silanizing agent tailored to surface bio-functionalization | |
| Li et al. | Click Chemistry‐Based Functionalization on Non‐Oxidized Silicon Substrates | |
| JP4591926B2 (ja) | 素材の表面改質方法 | |
| US8460923B2 (en) | Affinity hydrogel and label independent detection methods thereof | |
| EP1567569B1 (en) | Method for immobilizing biologic molecules on solid surfaces | |
| Ishihara et al. | Biomimetic phospholipid polymers for suppressing adsorption of saliva proteins on dental hydroxyapatite substrate | |
| EP1759761B1 (en) | Affinity particle and affinity separation method | |
| JP5013575B2 (ja) | 素材の表面処理方法 | |
| CN102884149B (zh) | 表面改质方法及表面改质材料 | |
| WO2003076933A1 (fr) | Surface en poly(ethylene oxyde) a structure de type pinceau presentant une densite elevee | |
| HK1162666A (en) | Surface-modified base plate, biochip and process for producing the biochip | |
| CN1956779B (zh) | 亲和颗粒和亲和分离方法 | |
| Dugas et al. | Use of organosilanes in biosensors | |
| Chan | Novel Silane Surface Chemistry for Covalent Immobilization with N-protected Histidine: Towards Improved Functionalization of Hydroxylated Materials with His-tagged Biomolecules | |
| JP2006322717A (ja) | センサチップおよびその製造方法 | |
| Fennell | Preparation of Aminosilane Surfaces for DNA Microarray Applications | |
| WO2006128644A1 (en) | Polymer coating and functionalization of solid surfaces | |
| TWI435880B (zh) | 矽殼之表面化學性改質及其應用 | |
| Zilio | A VERSTAILE POLYMERIC COATING FOR MICROARRAYS USING COPPER-MEDIATED CLICK CHEMISTRY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 201080007919.3 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10748721 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2011502749 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010748721 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13148680 Country of ref document: US |
|
| ENP | Entry into the national phase |
Ref document number: 20117018684 Country of ref document: KR Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |






















